NEPH 10-Q: SEC filing
Nephros Inc
Filed with the SEC on · accession 0001493152-26-050218
NEPH filed a 10-Q (quarterly report) with the SEC on Nov 5, 2026. Nephros Inc filed a 10-Q quarterly report with the SEC, accompanied by the standard Sarbanes-Oxley Section 302 certification from CEO Robert Banks.
Summary of the filing
Nephros Inc filed a 10-Q quarterly report with the SEC, accompanied by the standard Sarbanes-Oxley Section 302 certification from CEO Robert Banks. The certification confirms the accuracy of financial statements and the effectiveness of disclosure controls and internal controls over financial reporting.
Key details
✦ Ask GOAX AI about this filing — what it means for NEPH, what changed since its last filings and what to watch next.
Try it free for 7 days🔔 Want to stay updated on new SEC filings for NEPH?
Click hereFrequently asked questions
What did NEPH file with the SEC on Nov 5, 2026?
NEPH filed a 10-Q (SEC filing). Nephros Inc filed a 10-Q quarterly report with the SEC, accompanied by the standard Sarbanes-Oxley Section 302 certification from CEO Robert Banks. The certification confirms the accuracy of financial statements and the effectiveness of disclosure controls and internal controls over financial reporting.
How do I read a 10-Q?
The quarterly report: unaudited results for the quarter plus management’s comments. Compare revenue, margins and cash flow with the same quarter last year. Check MD&A for guidance changes and what drove the quarter.
Why are SEC filings important?
Public companies must tell the SEC about anything that can change their value — results, leadership changes, big deals, new shares, bankruptcy. Filings are the official source, often before the news. A 10-Q (quarterly report): The quarterly report: unaudited results for the quarter plus management’s comments.
Other NEPH SEC filings
Get alerts when NEPH files with the SEC, plus live charts, key levels and news for 13,000+ stocks.
Try SEPT free for 7 days